Carl L. Gordon
Director, BioCryst Pharmaceuticals.
Companies
- ADARx Pharmaceuticals, Inc.Board member Sep 24, 2026 to now1
- Electra Therapeutics, Inc.Board member Sep 18, 2026 to now2
- BlossomHill Therapeutics, Inc.Board member Aug 6, 2026 to now3
- Scribe Therapeutics, Inc.Board member Jul 23, 2026 to now4
- MBX Biosciences, Inc.Board member Sep 12, 2024 to now5
- Compass Therapeutics, Inc.Board member Jun 23, 2020 to now6
- Keros Therapeutics, Inc.Board member Apr 7, 2020 to now7
- Lomond Therapeutics Holdings, Inc.Board member Nov 5, 2024 to Nov 5, 20248
- Adicet Bio, Inc.Board member Sep 17, 2020 to Aug 23, 20249
- Terns Pharmaceuticals, Inc.Board member Feb 4, 2021 to Jul 17, 202410
- Kinnate Biopharma Inc.Board member Dec 2, 2020 to Apr 5, 202411
- Theseus Pharmaceuticals, Inc.Board member Oct 6, 2021 to Feb 14, 202412
- ArriVent BioPharma, Inc.Board member Jan 25, 2024 to Jan 31, 202413
- Disc Medicine, Inc.Board member Feb 10, 2021 to Oct 6, 202114
- Oric Pharmaceuticals, Inc.Board member Apr 23, 2020 to Jun 17, 202115
- Turning Point Therapeutics, Inc.Board member Apr 16, 2019 to Jun 17, 202016
- SpringWorks Therapeutics, Inc.Board member Sep 12, 2019 to Sep 12, 201917
- Alector (United States)Board member Feb 6, 2019 to May 14, 201918
- X4 Pharmaceuticals, IncBoard member Nov 15, 2017 to Jun 7, 201819
- Intellia TherapeuticsBoard member May 5, 2016 to May 19, 201720
- Selecta Biosciences (United States)Board member Jun 21, 2016 to Jun 29, 201621
- Acceleron PharmaBoard member Sep 18, 2013 to Sep 18, 201322
- Amarin CorporationBoard member Dec 30, 2010 to Sep 5, 201223
- Complete GenomicsBoard member Nov 10, 2010 to Feb 14, 201224
- Pacira BioSciences, Inc.Board member Feb 2, 2011 to Feb 10, 201125
- BioCryst PharmaceuticalsBoard member May 18, 2006 to May 18, 200626
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MBX Biosciences, Inc. MBX747,887 shares27$39.3M at $52.51Feb 18, 2025
- BlossomHill Therapeutics, Inc. BLSM2,714,279 shares28$37.0M at $13.62Aug 10, 2026
- ArriVent BioPharma, Inc. AVBP1,513,664 shares29$26.8M at $17.70Jan 30, 2024
- Scribe Therapeutics, Inc. SCTX1,348,825 shares30$26.5M at $19.62Jul 27, 2026
- Electra Therapeutics, Inc. ETRA1,758,279 shares31$15.3M at $8.69Sep 21, 2026
- Compass Therapeutics, Inc. CMPX15,219,994 shares32$12.8M at $0.84Apr 11, 2025
- ADARx Pharmaceuticals, Inc. ADRX588,235 shares33$10.4M at $17.71Sep 28, 2026
- Adicet Bio, Inc. ACET658,457 shares34$3.0M at $4.55Jun 7, 2024
- Keros Therapeutics, Inc. KROS50,307 shares35$555.4K at $11.04Nov 21, 2025
- Theseus Pharmaceuticals, Inc.0 shares36Feb 14, 2024
- Kinnate Biopharma Inc.0 shares37Apr 3, 2024
- Terns Pharmaceuticals, Inc.755,635 shares38Jul 16, 2024
- Lomond Therapeutics Holdings, Inc.2,677,256 shares39Nov 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 28, 2026Bought 588,235 shares at $17.00 of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Bought 61,516 shares at $17.00 of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 256,448 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 513,067 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 1,333,975 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 7,127,019 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Bought 300,249 shares at $17.00 of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 564,187 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 769,601 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 2,000,962 shares of ADARx Pharmaceuticals, Inc.33
- Sep 28, 2026Converted 10,690,530 shares of ADARx Pharmaceuticals, Inc.33
- Sep 21, 2026Bought 1,000,000 shares at $15.00 of Electra Therapeutics, Inc.31
- Sep 21, 2026Converted 758,279 shares of Electra Therapeutics, Inc.31
- Sep 21, 2026Bought 333,333 shares at $15.00 of Electra Therapeutics, Inc.31
- Sep 21, 2026Converted 1,703,314 shares of Electra Therapeutics, Inc.31
- Sep 21, 2026Converted 1,087,934 shares of Electra Therapeutics, Inc.31
- Sep 21, 2026Converted 2,002,310 shares of Electra Therapeutics, Inc.31
- Aug 10, 2026Bought 625,000 shares at $16.00 of BlossomHill Therapeutics, Inc.28
- Aug 10, 2026Converted 1,049,283 shares of BlossomHill Therapeutics, Inc.28
- Aug 10, 2026Converted 1,039,996 shares of BlossomHill Therapeutics, Inc.28
- Jul 27, 2026Bought 1,000,000 shares at $15.00 of Scribe Therapeutics, Inc.30
- Jul 27, 2026Converted 348,825 shares of Scribe Therapeutics, Inc.30
- Nov 21, 2025Returned to company 74,465 shares at $17.75 of Keros Therapeutics, Inc.35
- Nov 21, 2025Returned to company 140,057 shares at $17.75 of Keros Therapeutics, Inc.35
- Jun 4, 2025Granted 5,250 shares of Keros Therapeutics, Inc.40
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARMBX Biosciences, Inc., Board member
- 6
- 7
- 8
- 9SEC EDGARAdicet Bio, Inc., Board member
- 10
- 11SEC EDGARKinnate Biopharma Inc., Board member
- 12
- 13
- 14SEC EDGARDisc Medicine, Inc., Board member
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARIntellia Therapeutics, Board member
- 21
- 22SEC EDGARAcceleron Pharma, Board member
- 23SEC EDGARAmarin Corporation, Board member
- 24SEC EDGARComplete Genomics, Board member
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40SEC EDGARForm 4 filed Jun 6, 2025